- Home
- LUNG vs VNDA Comparison
LUNG vs VNDA Comparison
Compare LUNG & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- VNDA
- Stock Information
- Founded
- LUNG 1995
- VNDA 2002
- Country
- LUNG United States
- VNDA United States
- Employees
- LUNG N/A
- VNDA N/A
- Industry
- LUNG Industrial Specialties
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- LUNG Health Care
- VNDA Health Care
- Exchange
- LUNG Nasdaq
- VNDA Nasdaq
- Market Cap
- LUNG N/A
- VNDA 237.9M
- IPO Year
- LUNG 2020
- VNDA 2006
- Fundamental
- Price
- LUNG $3.64
- VNDA $4.22
- Analyst Decision
- LUNG Strong Buy
- VNDA Strong Buy
- Analyst Count
- LUNG 7
- VNDA 2
- Target Price
- LUNG $12.07
- VNDA $16.50
- AVG Volume (30 Days)
- LUNG 416.9K
- VNDA 500.0K
- Earning Date
- LUNG 04-30-2025
- VNDA 05-07-2025
- Dividend Yield
- LUNG N/A
- VNDA N/A
- EPS Growth
- LUNG N/A
- VNDA N/A
- EPS
- LUNG N/A
- VNDA N/A
- Revenue
- LUNG $87,473,000.00
- VNDA $201,351,000.00
- Revenue This Year
- LUNG $17.97
- VNDA $14.36
- Revenue Next Year
- LUNG $18.88
- VNDA $44.53
- P/E Ratio
- LUNG N/A
- VNDA N/A
- Revenue Growth
- LUNG 19.84
- VNDA 13.37
- 52 Week Low
- LUNG $4.15
- VNDA $3.85
- 52 Week High
- LUNG $10.01
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- LUNG 26.86
- VNDA 41.17
- Support Level
- LUNG $3.39
- VNDA $4.20
- Resistance Level
- LUNG $5.46
- VNDA $4.64
- Average True Range (ATR)
- LUNG 0.43
- VNDA 0.17
- MACD
- LUNG -0.06
- VNDA 0.01
- Stochastic Oscillator
- LUNG 12.92
- VNDA 20.75
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.